IRIX vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

IRIX

50.7
AI Score
VS
IRIX Wins

PACB

48.3
AI Score

Investment Advisor Scores

IRIX

51score
Recommendation
HOLD

PACB

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IRIX PACB Winner
Forward P/E 769.2308 0 Tie
PEG Ratio 0.939 -0.17 Tie
Revenue Growth -7.4% 5.5% PACB
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 50.7/100 48.3/100 IRIX
Profit Margin -6.9% -81.3% IRIX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IRIX 1M: -24.6% · 3M: -19.3% PACB 1M: +6.7% · 3M: +101.8%

Current Technical Phase

IRIX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.3%) with fading momentum, RSI 45

RSI (14): 45.2 · Price: $0.70

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $2.24

Fundamentals Snapshot

Metric IRIX PACB
Market Cap — —
Forward P/E 769.2 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.4% 0.3%
Operating Margin -0.1% -0.9%
EPS -0.20 -0.42
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IRIX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.